Cargando…
Circulating adipokines data associated with insulin secretagogue use in breast cancer patients
Oral drugs stimulating endogenous insulin production (insulin secretagogues) may have detrimental effects on breast cancer outcomes. The data presented shows the relationship between pre-existing insulin secretagogues use, adipokine profiles at the time of breast cancer (BC) diagnosis and subsequent...
Autores principales: | Wintrob, Zachary A.P., Hammel, Jeffrey P., Nimako, George K., Fayazi, Zahra S., Gaile, Dan P., Forrest, Alan, Ceacareanu, Alice C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155039/ https://www.ncbi.nlm.nih.gov/pubmed/27995161 http://dx.doi.org/10.1016/j.dib.2016.11.060 |
Ejemplares similares
-
Insulin secretagogue use and circulating inflammatory C–C chemokine levels in breast cancer patients
por: Wintrob, Zachary A.P., et al.
Publicado: (2017) -
Circulating growth factors data associated with insulin secretagogue use in women with incident breast cancer
por: Wintrob, Zachary A.P., et al.
Publicado: (2017) -
Dataset on granulopoiesis- and lymphopoiesis-stimulating cytokine levels in insulin secretagogue users with incident breast cancer
por: Wintrob, Zachary A.P., et al.
Publicado: (2017) -
TH1 and TH2 cytokine data in insulin secretagogues users newly diagnosed with breast cancer
por: Wintrob, Zachary A.P., et al.
Publicado: (2017) -
Insulin use, hormone receptor status and hematopoietic cytokines׳ circulation in women with diabetes mellitus and breast cancer
por: Wintrob, Zachary A.P., et al.
Publicado: (2017)